Ischaemic heart disease

Evidence catches up with clinical practice on beta-blockers

A French study has provided evidence that extended use of beta-blockers does not provide any survival benefit for patients after acute myocardial infarction. The findings validate what most Australian clinicians are already doing – discontinuing the drugs after about 12 months for MI patients without heart failure or LV dysfunction. Associate Professor John Amerena, director ...

Already a member?

Login to keep reading.

© 2021 the limbic